RivkaRivka
Senior Member
- Messages
- 368
== What happened to the FDA campaign that was just started and aborted? ==
This was written by me (Rivka) alone. I am only speaking for myself here.
1) FDA CAMPAIGN
In terms of this December 2010 FDA campaign targeting the Blood Working Group and Blood Products Advisory Committee, organized by Rivka and a 3 other patients who wish to remain anonymous:
What I can say about this, and why the FDA campaign was aborted 7 hours after it was started, is that we are still learning as we go with all this advocacy, including who to target and what to ask for (what to demand). Because not all information is available to us patients, we make calculated decisions on the information that IS available to us. But there may be things we do not know. For example, we are still learning who is on our side and who is not (both individuals and groups).
Just a few hours after publicizing the FDA campaign (making it public, starting it) I was asked by Dr. Judy Mikovits to to stop it. (She has now agreed that I may state this publicly.) Seeking clarification, I was told that our campaign was not helpful (to put it gently) to the work they were feverishing pursuing. We patients who worked on this FDA campaign worked hard on it and had thought it could have a good impact. Believe me when I tell you, we did not want to abort the mission unless we had good reason. And being asked by Judy Mikovits, hero to many of us, to stop it seemed like a darn good reason.
2) NIH CAMPAIGN
Since folks have asked about this campaign, too. Here is my reply...
In terms of the fall 2010 "Time For Action" campaign of a daily email/call/fax to the NIH:
This NIH campaign was stopped a couple of weeks after it started, and only after it yielded some successes, not like the December FDA campaign that was aborted before it really got going.
Personally, I actually do feel we stopped that NIH campaign too early. But there were others in my trio who worked on that campaign with me who attended the CFSAC meeting (I did not) who felt strongly that we should stop it.
There are pros and cons to working with a group, in this case, a trio. One of the pros is that more gets done in a group. And one of the cons is that it can be hard to reach consensus. And sometimes you can't. Yet I still felt it was important to act as a team. So I signed on to the decision to stop that NIH campaign. I regretted the decision immediately after we stopped the campaign, even before the publication went out. I am new at this. I made a mistake. I should have not signed on to that decision and instead should have graciously bowed out of adding my name to that decision. Live and learn. After that decision, I pulled out of working in that trio, as it was clear we had/have different views on advocacy strategies and priorities. I parted from the trio respectfully and amicably.
FINAL THOUGHT
I am learning-as-I-go how to fight for ME/CFS issues. So either I can *not* take any action -- which means not take any risks and thus not make any mistakes -- or I can take action and thus take the risk of making mistakes. I have chosen the latter. So I will likely make more mistakes, but with luck, less and less as I go.
I hope others will join me in taking more risks and doing more actions, including public actions (for those who are able), in putting themselves out there, even at the risk of making mistakes. I mean, nothing will change unless we do just that.
So come on board, everyone, get on the TAKE A RISK train for ME/CFS advocacy and activism. If we all get on board, maybe we can finally get clinical trials, treatments, a vaccine and who knows, maybe a cure!
With great respect for the ME/CFS community,
Rivka
This was written by me (Rivka) alone. I am only speaking for myself here.
1) FDA CAMPAIGN
In terms of this December 2010 FDA campaign targeting the Blood Working Group and Blood Products Advisory Committee, organized by Rivka and a 3 other patients who wish to remain anonymous:
What I can say about this, and why the FDA campaign was aborted 7 hours after it was started, is that we are still learning as we go with all this advocacy, including who to target and what to ask for (what to demand). Because not all information is available to us patients, we make calculated decisions on the information that IS available to us. But there may be things we do not know. For example, we are still learning who is on our side and who is not (both individuals and groups).
Just a few hours after publicizing the FDA campaign (making it public, starting it) I was asked by Dr. Judy Mikovits to to stop it. (She has now agreed that I may state this publicly.) Seeking clarification, I was told that our campaign was not helpful (to put it gently) to the work they were feverishing pursuing. We patients who worked on this FDA campaign worked hard on it and had thought it could have a good impact. Believe me when I tell you, we did not want to abort the mission unless we had good reason. And being asked by Judy Mikovits, hero to many of us, to stop it seemed like a darn good reason.
2) NIH CAMPAIGN
Since folks have asked about this campaign, too. Here is my reply...
In terms of the fall 2010 "Time For Action" campaign of a daily email/call/fax to the NIH:
This NIH campaign was stopped a couple of weeks after it started, and only after it yielded some successes, not like the December FDA campaign that was aborted before it really got going.
Personally, I actually do feel we stopped that NIH campaign too early. But there were others in my trio who worked on that campaign with me who attended the CFSAC meeting (I did not) who felt strongly that we should stop it.
There are pros and cons to working with a group, in this case, a trio. One of the pros is that more gets done in a group. And one of the cons is that it can be hard to reach consensus. And sometimes you can't. Yet I still felt it was important to act as a team. So I signed on to the decision to stop that NIH campaign. I regretted the decision immediately after we stopped the campaign, even before the publication went out. I am new at this. I made a mistake. I should have not signed on to that decision and instead should have graciously bowed out of adding my name to that decision. Live and learn. After that decision, I pulled out of working in that trio, as it was clear we had/have different views on advocacy strategies and priorities. I parted from the trio respectfully and amicably.
FINAL THOUGHT
I am learning-as-I-go how to fight for ME/CFS issues. So either I can *not* take any action -- which means not take any risks and thus not make any mistakes -- or I can take action and thus take the risk of making mistakes. I have chosen the latter. So I will likely make more mistakes, but with luck, less and less as I go.
I hope others will join me in taking more risks and doing more actions, including public actions (for those who are able), in putting themselves out there, even at the risk of making mistakes. I mean, nothing will change unless we do just that.
So come on board, everyone, get on the TAKE A RISK train for ME/CFS advocacy and activism. If we all get on board, maybe we can finally get clinical trials, treatments, a vaccine and who knows, maybe a cure!
With great respect for the ME/CFS community,
Rivka